Related Experiment Video
Updated: Dec 23, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral venous thrombosis: Associations between disease severity and cardiac markers
Michelle C Johansen1, Rebecca F Gottesman1, Victor C Urrutia1
1Department of Neurology, the Johns Hopkins University School of Medicine, Baltimore, MD.
Insights
Cardiac troponin (cTn) elevation is linked to cerebral venous thrombosis (CVT) severity. Increased cTn levels in CVT patients may indicate poorer outcomes, warranting further research into this association.
Area of Science:
- Neurology
- Cardiology
- Radiology
Background:
- Elevated plasma cardiac troponin (cTn) is observed in acute stroke and intracranial hemorrhage, often indicating a poor prognosis.
- Cerebral venous thrombosis (CVT) can cause venous stasis and cardiac stress, necessitating an evaluation of cTn levels in affected patients.
Purpose of the Study:
- To investigate the association between the severity of cerebral venous thrombosis (CVT) and the elevation of cardiac troponin (cTn).
Main Methods:
- A retrospective study of inpatients diagnosed with CVT between 2005 and 2015.
- Analysis of electrocardiogram (ECG) abnormalities and cTn levels (>0.06 ng/mL) in relation to CVT location and severity.
- Regression models adjusted for age, sex, and hypertension.
Main Results:
- Of 53 CVT patients included, 41% exhibited cTn elevation.
- Each additional thrombosed vein increased the odds of cTn elevation (adjusted OR 2.79).
- Deep venous involvement and venous infarction were significantly associated with higher cTn levels.
Conclusions:
- CVT severity markers correlate with increased odds of cTn elevation.
- Further research is required to understand the causal relationship and clinical significance of cTn elevation in CVT.
Background:
Plasma cardiac troponin (cTn) elevation occurs in acute ischemic stroke and intracranial hemorrhage and can suggest a poor prognosis. Because acute cerebral venous thrombosis (CVT) might lead to venous stasis, which could result in cardiac stress, it is important to evaluate whether cTn elevation occurs in patients with CVT.
Methods:
Inpatients at Johns Hopkins Hospital from 2005 to 2015 meeting the following criteria were included: CVT (ICD-9 codes with radiologic confirmation) and available admission electrocardiogram (ECG) and cTn level. In regression models, presence of ECG abnormalities and cTn elevation (>0.06 ng/mL) were evaluated as dependent variables in separate models, with location and severity of CVT involvement as independent variables, adjusted for age, sex, and hypertension.
Results:
Of 81 patients with CVST, 53 (66%) met the inclusion criteria. Participants were, on average, aged 42 years, white (71%), and female (66%). The left transverse sinus was most commonly thrombosed (47%), with 66% having >2 veins thrombosed. Twenty-two (41%) had cTn elevation. Odds of cTn elevation increased per each additional vein thrombosed (adjusted OR 2.79, 95% CI [1.08-7.23]). Of those with deep venous involvement, 37.5% had cTn elevation compared with 4.4% without deep clots (p = 0.02). Venous infarction (n = 15) was associated with a higher mean cTn (0.14 vs 0.02 ng/mL, p = 0.009) and was predictive of a higher cTn in adjusted models (β = 0.15, 95% CI [0.06-0.25]).
Conclusions:
In this single-center cohort study, markers of CVT severity were associated with increased odds of cTn elevation; further investigation is needed to elucidate causality and significance.
More Related Videos
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
06:02Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Venous Thrombosis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies